Enveric Biosciences, Inc. (ENVB) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 5.38M | 4.94M | 4.17M | 3.31M | 4.83M | 2.73M | 4.34M | 5.52M | 8.23M | 3.58M | 5.83M | 8.9M |
| Cash & Short-Term Investments | 4.91M | 4.68M | 3.76M | 2.85M | 4.29M | 2.24M | 3.11M | 3.5M | 6.36M | 2.29M | 4.27M | 7.08M |
| Cash Only | 4.91M | 4.68M | 3.76M | 2.85M | 4.29M | 2.24M | 3.11M | 3.5M | 6.36M | 2.29M | 4.27M | 7.08M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 17.76K | 299.32K | 0 | 224.61K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 65.41K | 0 | 0 | -17.76K | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | 148.89 | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 43.25K | 407.95K | 3.16K | 0 | 0 | 772.33K | 763.17K | 1.09M | 567.6K | 1.56M | 222.33K |
| Total Non-Current Assets | 146.37K | 159.23K | 196.52K | 241.08K | 267.28K | 347.96K | 452.06K | 531.67K | 620.97K | 718.31K | 792.27K | 900.15K |
| Property, Plant & Equipment | 119.93K | 159.23K | 196.52K | 241.08K | 267.28K | 305.78K | 367.69K | 405.11K | 452.23K | 507.38K | 539.15K | 604.84K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 42.18K | 84.37K | 126.56K | 168.74K | 210.93K | 253.12K | 295.31K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 26.44K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 5.52M | 5.1M | 4.36M | 3.55M | 5.1M | 3.08M | 4.79M | 6.05M | 8.85M | 4.3M | 6.62M | 9.8M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 8.22% | 65.32% | -8.94% | -41.36% | -42.35% | -28.31% | -27.63% | -38.25% | -44.17% | -78.01% | -78.55% | -65.7% |
| Total Current Liabilities | 460.68K | 918.4K | 905.88K | 1.36M | 1.18M | 1.49M | 839.17K | 645.34K | 2.37M | 2.34M | 4.18M | 4.93M |
| Accounts Payable | 280.31K | 581.02K | 683.71K | 1.04M | 669.19K | 521.75K | 576.32K | 459.9K | 1.85M | 1.22M | 1.1M | 1.23M |
| Days Payables Outstanding | 1.04K | 1.47K | 1.97K | 1.95K | 661.44 | 612.35 | 562.01 | 1.24K | 1.64K | 1.26K | 1.12K | 1.2K |
| Short-Term Debt | 0 | 0 | 0 | 99.88K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 123.57K | 251.51K | 222.18K | 0 | 0 | 3.09K | 9.69K | 176.81K | 141.17K | 350.72K | 2.15M | 2.9M |
| Current Ratio | 11.67x | 5.38x | 4.60x | 2.43x | 4.08x | 1.84x | 5.17x | 8.55x | 3.48x | 1.53x | 1.39x | 1.81x |
| Quick Ratio | 11.67x | 5.38x | 4.60x | 2.38x | 4.08x | 1.84x | 5.19x | 8.55x | 3.48x | 1.53x | 1.39x | 1.81x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 460.68K | 918.4K | 905.88K | 1.36M | 1.18M | 1.49M | 839.17K | 645.34K | 2.37M | 2.34M | 4.18M | 4.93M |
| Total Debt | 0 | 0 | 0 | 99.88K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.61K |
| Net Debt | -4.91M | -4.68M | -3.76M | -2.75M | -4.29M | -2.24M | -3.11M | -3.5M | -6.36M | -2.29M | -4.27M | -7.07M |
| Debt / Equity | - | - | - | 0.05x | - | - | - | - | - | - | - | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -5390.00x | -8775.69x | - | -19084.69x | - | - | - | -53696.83x | - | - | - | - |
| Total Equity | 5.06M | 4.18M | 3.46M | 2.18M | 3.92M | 1.59M | 3.95M | 5.41M | 6.48M | 1.96M | 2.44M | 4.87M |
| Equity Growth % | 29.18% | 162.28% | -12.53% | -59.59% | -39.56% | -18.58% | 62.22% | 10.91% | -43.21% | -87.42% | -89.68% | -78.43% |
| Book Value per Share | 3.35 | 3.94 | 11.03 | 10.10 | 26118.09 | 29.18 | 33.70 | 46.11 | 55.28 | 19.08 | 23.76 | 47.54 |
| Total Shareholders' Equity | 5.06M | 4.18M | 3.46M | 2.18M | 3.92M | 1.59M | 3.95M | 5.41M | 6.48M | 1.96M | 2.44M | 4.87M |
| Common Stock | 18.88K | 10.62K | 5.18K | 30.26K | 24.72K | 6.78K | 89.95K | 78.78K | 72.94K | 27.39K | 21.82K | 21.42K |
| Retained Earnings | -116.48M | -114.85M | -112.65M | -110.78M | -108.26M | -106.07M | -102.92M | -100.84M | -98.96M | -96.5M | -93.06M | -90.24M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -587.06K | -580.04K | -580.95K | -573.53K | -598K | -594.52K | -535K | -566.5K | -551.84K | -569.75K | -535.62K | -546.05K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |